Co-blockade of mecR1/blaR1 signal pathway to restore antibiotic susceptibility in clinical isolates of methicillin-resistant Staphylococcus aureus

Archives of Medical Science

Volumn 7, Issue 3, 2011, Pages 414-422

  Hou, Zheng ^a   Zhou, Ying ^a   Wang, Haifang ^b   Bai, Hui ^a   Meng, Jingru ^a   Xue, Xiaoyan ^a   Luo, Xiaoxing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

Author keywords

blaR1; mecR1; Methicillin resistant Staphylococcus aureus; Phospho rothioate deoxyribozyme

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; BLAR1 PROTEIN; DEOXYRIBOZYME; MECR1 PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE DELETION; GENE SILENCING; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STRUCTURE; SIGNAL TRANSDUCTION;

EID: 79960471860     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.23404     Document Type: Article

References (28)

1. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Jama 2007; 298: 1763-71. (Pubitemid 47598444)
2. Bancroft EA. Antimicrobial resistance: it's not just for hospitals. JAMA 2007; 298: 1803-04. (Pubitemid 47598451)
3. Lloyd-Smith E, Hull MW, Tyndall MW, et al. Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users. Epidemiol Infect 2010; 138: 713-20.
4. Delaney JA, Schneider-Lindner V, Brassard P, Suissa S. Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community. BMC Med 2008; 6: 2.
5. Neoh HM, Hori S, Komatsu M, et al. Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections. Ann Clin Microbiol Antimicrob 2007; 6: 13.
6. Weigel LM, Donlan RM, Shin DH, et al. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother 2007; 51: 231-8. (Pubitemid 46047711)
7. Hill RL, Kearns AM, Nash J, et al. Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients. J Antimicrob Chemother 2010; 65: 442-5.
8. Falagas ME, Vardakas KZ. Benefit-risk assessment of linezolid for serious gram-positive bacterial infections. Drug Saf 2008; 31: 753-68.
9. Morales G, Picazo JJ, Baos E, et al. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis 2010; 50: 821-5.
10. Yoshida K, Shoji H, Hanaki H, et al. Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid. J Infect Chemother 2009; 15: 417-9.
11. Archer GL, Bosilevac JM. Signaling antibiotic resistance in staphylococci. Science 2001; 291: 1915-6. (Pubitemid 32216984)
12. Suzuki E, Kuwahara-Arai K, Richardson JF, Hiramatsu K. Distribution of mec regulator genes in methicillin-resistant Staphylococcus clinical strains. Antimicrob Agents Chemother 1993; 37: 1219-26. (Pubitemid 23166717)
13. Hackbarth CJ, Chambers HF. blaI and blaR1 regulate beta-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1993; 37: 1144-9. (Pubitemid 23141334)
14. Lewis RA, Dyke KG. mecI represses synthesis from the beta-lactamase operon of Staphylococcus aureus. J Antimicrob Chemother 2000; 45: 139-44. (Pubitemid 30095183)
15. McKinney TK SV, Craig WA, Archer GL. Transcription of the gene mediating methicillin resistance in Staphylococcus aureus (mecA) is corepressed but not coinduced by cognate mecA and betalactamase regulators. J Bacteriol 2001; 183: 6862-8. (Pubitemid 33064200)
16. Hou Z, Meng JR, Niu C, et al. Restoration of antibiotic susceptibility in methicillin-resistant Staphylococcus aureus by targeting mecR1 with a phosphorothioate deoxyribozyme. Clin Exp Pharmacol Physiol 2007; 34: 1160-4. (Pubitemid 47416360)
17. Hou Z, Meng JR, Zhao JR, et al. Inhibition of beta-lactamase-mediated oxacillin resistance in Staphylococcus aureus by a deoxyribozyme. Acta Pharmacol Sin 2007; 28: 1775-82. (Pubitemid 350029322)
18. Weller TM. The distribution of mecA, mecR1 and mecI and sequence analysis of mecI and the mec promoter region in staphylococci expressing resistance to methicillin. J Antimicrob Chemother 1999; 43: 15-22. (Pubitemid 29045927)
19. Kobayashi N, Taniguchi K, Urasawa S. Analysis of diversity of mutations in the mecI gene and mecA promoter/ operator region of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 1998; 42: 717-20. (Pubitemid 28114838)
20. Rosato AE, Kreiswirth BN, Craig WA, Eisner W, Climo MW, Archer GL. mecA-blaZ corepressors in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother 2003; 47: 1460-3. (Pubitemid 36368621)
21. Serefko A, Malm A. Sensitivity of Candida albicans isolates to caspofungin - comparison of microdilution method and E-test procedure. Arch Med Sci 2009; 5: 23-7.
22. Matveeva OV, Mathews DH, Tsodikov AD, et al. Thermo-dynamic criteria for high hit rate antisense oligonucleotide design. Nucleic Acids Res 2003; 31: 4989-94. (Pubitemid 37441865)
23. Cairns MJ, Hopkins TM, Witherington C, et al. Target site selection for an RNA-cleaving catalytic DNA. Nat Biotechnol 1999; 17: 480-6. (Pubitemid 29217902)
24. Rasmussen LC, Sperling-Petersen HU, Mortensen KK. Hitting bacteria at the heart of the central dogma: sequence-specific inhibition. Microb Cell Fact 2007; 6: 24.
25. Baum DA, Silverman SK. Deoxyribozymes: useful DNA catalysts in vitro and in vivo. Cell Mol Life Sci 2008; 65: 2156-74.
26. Fahmy RG, Waldman A, Zhang G, et al. Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun. Nat Biotechnol 2006; 24: 856-63. (Pubitemid 44086629)
27. Zhang L, Gasper WJ, Stass SA, Ioffe OB, Davis MA, Mixson AJ. Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2. Cancer Res 2002; 62: 5463-9.
28. Safo MK, Zhao Q, Ko TP, et al. Crystal structures of the BlaI repressor from Staphylococcus aureus and its complex with DNA: insights into transcriptional regulation of the bla and mec operons. J Bacteriol 2005; 187: 1833-44. (Pubitemid 40289385)